Hospital
Ruston Louisiana Hospital Company LLC
Ruston Louisiana Hospital Company LLC was paid $2.94M by Medicaid between Jan 2018 and Sep 2020, across 93 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoRUSTON LOUISIANA HOSPITAL COMPANY LLC
RUSTON, LA 71270
RUSTON, LA 71270
33aNPI1285765107assigned 03/09/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.94M
24GClaims94,171
24DCodes billed93
24AFirst – last monthJan 2018 – Sep 2020
Compared with peers
Next to other General Acute Care Hospital providers in Louisiana
Rank by total paid#59 of 96
Median peer was paid$5.17M
This provider vs. median0.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,272 | $1.19M | |
| 2019 | 35,502 | $1.21M | |
| 2020 | 18,397 | $541K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 13,853 | 12,388 | $859K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 7,501 | 6,644 | $783K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 7.4% | 1,544 | 615 | $218K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 3,342 | 3,085 | $137K |
| 71046 | Radiologic examination, chest; 2 views | 3.0% | 2,417 | 2,199 | $87K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.7% | 2,755 | 2,537 | $78K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.4% | 612 | 548 | $72K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.3% | 440 | 398 | $68K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 2,081 | 1,899 | $53K |
| 80053 | Comprehensive metabolic panel | 1.8% | 7,262 | 6,308 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 9,671 | 8,321 | $52K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 1,217 | 1,073 | $40K |
81 more codes
| 29881 | 1.3% | 68 | $38K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 1.2% | 139 | $37K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 982 | $33K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 1,982 | $33K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 583 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,133 | $24K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,294 | $23K |
| 81001 | <1% | 6,506 | $16K | |
| 80050 | General health panel | <1% | 383 | $15K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,969 | $13K |
| G0378 | Hospital observation service, per hour | <1% | 245 | $13K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 60 | $13K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 305 | $12K |
| 81025 | <1% | 1,858 | $12K | |
| 84484 | <1% | 1,489 | $10K | |
| 82553 | <1% | 1,334 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,667 | $9K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 12 | $8K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 542 | $8K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,317 | $6K |
| 82550 | <1% | 1,493 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 196 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 910 | $6K |
| 80061 | Lipid panel | <1% | 487 | $5K |
| 72100 | <1% | 129 | $5K | |
| 84439 | <1% | 510 | $4K | |
| 87081 | <1% | 535 | $3K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 44 | $3K |
| 83690 | <1% | 626 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 576 | $3K |
| 17250 | <1% | 103 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,178 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 307 | $2K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,975 | $2K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 26 | $2K |
| 84480 | <1% | 354 | $2K | |
| 97597 | <1% | 114 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 34 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 257 | $1K |
| 83880 | <1% | 78 | $1K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 129 | $947.90 |
| 87420 | <1% | 66 | $862.92 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 40 | $807.40 |
| 81003 | <1% | 403 | $781.21 | |
| 83735 | <1% | 148 | $780.54 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 111 | $772.38 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 100 | $746.38 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $658.20 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 70 | $595.07 |
| 73562 | <1% | 14 | $572.61 | |
| 86140 | <1% | 123 | $556.61 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $509.04 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $509.04 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 25 | $500.00 |
| 82150 | <1% | 120 | $485.75 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,056 | $468.76 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 13 | $462.12 |
| 96376 | <1% | 12 | $361.20 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 939 | $325.84 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 83 | $303.26 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 12 | $266.40 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 15 | $200.06 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 440 | $177.86 |
| 80320 | <1% | 12 | $161.52 | |
| 86038 | <1% | 12 | $135.10 | |
| 86403 | <1% | 12 | $113.90 | |
| 83550 | <1% | 13 | $88.65 | |
| 87077 | <1% | 13 | $80.73 | |
| 82043 | <1% | 12 | $58.32 | |
| 85027 | <1% | 17 | $58.11 | |
| 82962 | <1% | 31 | $57.73 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 944 | $54.16 |
| 83540 | <1% | 13 | $51.12 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 45 | $27.95 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 371 | $8.89 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 29 | $5.76 |
| C1780 | Lens, intraocular (new technology) | 0% | 44 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 39 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 38 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 25 | $0.00 |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 48 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.